HCA Healthcare, Inc. $HCA is Tranquility Partners LLC’s 7th Largest Position

Tranquility Partners LLC cut its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 0.5% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 16,556 shares of the company’s stock after selling 89 shares during the period. HCA Healthcare makes up 2.3% of Tranquility Partners LLC’s investment portfolio, making the stock its 7th biggest holding. Tranquility Partners LLC’s holdings in HCA Healthcare were worth $6,343,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of HCA Healthcare by 11.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company’s stock worth $8,796,000 after buying an additional 2,698 shares in the last quarter. Park Place Capital Corp raised its stake in shares of HCA Healthcare by 2,336.0% during the 2nd quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock worth $474,000 after buying an additional 1,168 shares in the last quarter. Harrell Investment Partners LLC increased its stake in HCA Healthcare by 176.3% in the 2nd quarter. Harrell Investment Partners LLC now owns 1,815 shares of the company’s stock valued at $695,000 after purchasing an additional 1,158 shares in the last quarter. Brown Advisory Inc. increased its stake in HCA Healthcare by 53.9% in the 1st quarter. Brown Advisory Inc. now owns 4,630 shares of the company’s stock valued at $1,600,000 after purchasing an additional 1,622 shares in the last quarter. Finally, Farther Finance Advisors LLC increased its stake in HCA Healthcare by 26.9% in the 1st quarter. Farther Finance Advisors LLC now owns 1,141 shares of the company’s stock valued at $395,000 after purchasing an additional 242 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Stock Down 1.0%

HCA stock opened at $414.73 on Friday. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $439.01. The stock’s fifty day simple moving average is $405.12 and its 200-day simple moving average is $375.85. The stock has a market capitalization of $97.04 billion, a price-to-earnings ratio of 17.43, a price-to-earnings-growth ratio of 1.31 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.20 by $0.64. The business had revenue of $18.61 billion for the quarter, compared to analysts’ expectations of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The business’s revenue was up 6.4% on a year-over-year basis. During the same quarter last year, the firm earned $5.50 earnings per share. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th were given a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is 12.11%.

Insider Buying and Selling at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the transaction, the executive vice president directly owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 1.30% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the company. Robert W. Baird raised their price objective on HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a research note on Thursday, August 14th. Wells Fargo & Company increased their target price on HCA Healthcare from $375.00 to $412.00 and gave the company an “equal weight” rating in a report on Tuesday. Bank of America increased their target price on HCA Healthcare from $375.00 to $410.00 and gave the company a “neutral” rating in a report on Wednesday, September 10th. JPMorgan Chase & Co. increased their target price on HCA Healthcare from $360.00 to $370.00 and gave the company a “neutral” rating in a report on Monday, August 4th. Finally, KeyCorp increased their target price on HCA Healthcare from $370.00 to $465.00 and gave the company an “overweight” rating in a report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and a consensus price target of $422.31.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.